Literature DB >> 21998172

UK national guideline for the management of gonorrhoea in adults, 2011.

C Bignell1, M Fitzgerald.   

Abstract

The British Association for Sexual Health and HIV (BASHH) UK gonorrhoea guideline has been updated in 2011. It offers advice on diagnosis, treatment and health promotion for anogenital and pharyngeal gonorrhoea. Nucleic acid amplification tests (NAATs) are now being used more for diagnosis and are increasing detection rates in the pharynx and rectum. First line treatment using ceftriaxone with azithromycin is now advised, along with routine test of cure (TOC). The aim is to slow the spread of resistant gonorrhoea now that fewer antibiotics remain effective. A patient information leaflet has been developed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998172     DOI: 10.1258/ijsa.2011.011267

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  72 in total

Review 1.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

2.  Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.

Authors:  Daniel Golparian; Stina Boräng; Martin Sundqvist; Magnus Unemo
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

Review 3.  Preparing for an era of untreatable gonorrhea.

Authors:  Lindley A Barbee
Journal:  Curr Opin Infect Dis       Date:  2014-06       Impact factor: 4.915

4.  Emergence and Spread of Neisseria gonorrhoeae Strains with High-Level Resistance to Azithromycin in Taiwan from 2001 to 2018.

Authors:  Yen-Hung Liu; Ya-Hui Wang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

5.  Bone and joint infection.

Authors:  Julia Colston; Bridget Atkins
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

Review 6.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  Gonorrhea: Treatment update for an increasingly resistant organism.

Authors:  Jolanta Piszczek; Renée St Jean; Yasmin Khaliq
Journal:  Can Pharm J (Ott)       Date:  2015-03

8.  Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.

Authors:  Magnus Unemo; Daniel Golparian; Vegard Skogen; Anne Olaug Olsen; Harald Moi; Gaute Syversen; Stig Ove Hjelmevoll
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

Review 9.  Surveillance of antibiotic resistance.

Authors:  Alan P Johnson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

10.  Gonococcal cellulitis: an (un)friendly bite.

Authors:  Amos Lal; Alwyn Rapose
Journal:  Infection       Date:  2018-03-16       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.